Q3 2018 Earnings Forecast for Walgreens Boots Alliance Inc (WBA) Issued By Jefferies Group

Walgreens Boots Alliance Inc (NASDAQ:WBA) – Analysts at Jefferies Group cut their Q3 2018 earnings per share (EPS) estimates for Walgreens Boots Alliance in a note issued to investors on Tuesday, April 3rd. Jefferies Group analyst B. Tanquilut now expects that the pharmacy operator will earn $1.43 per share for the quarter, down from their prior forecast of $1.53. Jefferies Group has a “Buy” rating and a $85.00 price objective on the stock. Jefferies Group also issued estimates for Walgreens Boots Alliance’s FY2019 earnings at $6.55 EPS.

WBA has been the topic of several other research reports. Royal Bank of Canada set a $88.00 price target on Walgreens Boots Alliance and gave the stock a “buy” rating in a research note on Wednesday, March 28th. They noted that the move was a valuation call. BidaskClub upgraded Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research note on Thursday, March 29th. Scotiabank cut their price target on Walgreens Boots Alliance from $93.00 to $91.00 and set an “outperform” rating on the stock in a research note on Monday, April 2nd. Needham & Company LLC reiterated a “buy” rating and issued a $88.00 price target (up previously from $86.00) on shares of Walgreens Boots Alliance in a research note on Wednesday, January 10th. Finally, Pivotal Research set a $70.00 price target on Walgreens Boots Alliance and gave the stock a “hold” rating in a research note on Thursday, March 29th. One research analyst has rated the stock with a sell rating, ten have given a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the company. The stock presently has a consensus rating of “Buy” and an average price target of $83.35.

Shares of WBA opened at $63.47 on Thursday. The stock has a market cap of $64,964.02, a price-to-earnings ratio of 12.45, a P/E/G ratio of 1.06 and a beta of 1.16. Walgreens Boots Alliance has a 12 month low of $61.74 and a 12 month high of $87.79. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.45 and a current ratio of 0.90.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Wednesday, March 28th. The pharmacy operator reported $1.73 EPS for the quarter, topping the Zacks’ consensus estimate of $1.55 by $0.18. The company had revenue of $33.02 billion for the quarter, compared to analysts’ expectations of $32.20 billion. Walgreens Boots Alliance had a return on equity of 20.38% and a net margin of 3.33%. The firm’s quarterly revenue was up 12.1% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.36 earnings per share.

Several large investors have recently bought and sold shares of WBA. Arrowstreet Capital Limited Partnership grew its holdings in shares of Walgreens Boots Alliance by 675.5% during the fourth quarter. Arrowstreet Capital Limited Partnership now owns 5,891,845 shares of the pharmacy operator’s stock valued at $427,866,000 after purchasing an additional 5,132,140 shares during the last quarter. LSV Asset Management grew its holdings in shares of Walgreens Boots Alliance by 38,624.0% during the fourth quarter. LSV Asset Management now owns 3,678,780 shares of the pharmacy operator’s stock valued at $267,153,000 after purchasing an additional 3,669,280 shares during the last quarter. Two Sigma Advisers LP grew its holdings in shares of Walgreens Boots Alliance by 315.6% during the fourth quarter. Two Sigma Advisers LP now owns 2,639,155 shares of the pharmacy operator’s stock valued at $191,655,000 after purchasing an additional 2,004,131 shares during the last quarter. CI Global Investments Inc. grew its holdings in shares of Walgreens Boots Alliance by 32.0% during the fourth quarter. CI Global Investments Inc. now owns 7,373,589 shares of the pharmacy operator’s stock valued at $535,470,000 after purchasing an additional 1,785,449 shares during the last quarter. Finally, Amundi Pioneer Asset Management Inc. grew its holdings in shares of Walgreens Boots Alliance by 875.2% during the fourth quarter. Amundi Pioneer Asset Management Inc. now owns 1,650,553 shares of the pharmacy operator’s stock valued at $119,862,000 after purchasing an additional 1,481,305 shares during the last quarter. 60.94% of the stock is owned by institutional investors.

In other news, insider Stefano Pessina acquired 98,858 shares of the stock in a transaction that occurred on Monday, January 15th. The stock was purchased at an average cost of $76.07 per share, with a total value of $7,520,128.06. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 14.80% of the stock is owned by insiders.

The company also recently disclosed a quarterly dividend, which was paid on Monday, March 12th. Investors of record on Thursday, February 15th were issued a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 2.52%. The ex-dividend date was Wednesday, February 14th. Walgreens Boots Alliance’s dividend payout ratio is currently 31.37%.

COPYRIGHT VIOLATION WARNING: “Q3 2018 Earnings Forecast for Walgreens Boots Alliance Inc (WBA) Issued By Jefferies Group” was originally reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this article on another website, it was illegally stolen and republished in violation of U.S. and international copyright law. The legal version of this article can be viewed at https://www.dispatchtribunal.com/2018/04/07/q3-2018-earnings-forecast-for-walgreens-boots-alliance-inc-wba-issued-by-jefferies-group.html.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Earnings History and Estimates for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply